Table 2.
Summary of available molecular assays protocols for COVID-19 diagnosis as per WHO [[43], [44], [45], [46], [47], [48], [49]].
| Gene targets | Institute | Country |
|---|---|---|
| ORF1ab and N | China CDC | China |
| RdRP, E, N | Charité | Germany |
| ORF1b-nsp14, N | University of Hong Kong | Hong Kong |
| Pancorona and multiple targets, Spike protein | National Institute of Infectious Diseases, Department of Virology III | Japan |
| N | National Institute of Health | Thailand |
| Three targets in N gene | United States CDC | US |
| Two targets in RdRP | Institut Pasteur, Paris | France |